4
Changes in Ownership
Lantern Pharma Inc. Filed Acc 0001493152-24-028182
Options or other derivatives
- Chief Scientific Officer acquired 35,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Bhatia Kishor G. · Chief Scientific Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-07-15 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +35,000 | 35,000 | D |
Loading xslF345X05/ownership.xml…